or
forgot password

    • cancer clinical trials in wynnewood, PA

    • Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mainline Health CCOP
    Wynnewood, Pennsylvania 19096
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Cervical Cancer, Endometrial Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    CCOP - MainLine Health

    Trial Locations
    CCOP - MainLine Health
    Lankenau Cancer Center at Lankenau Hospital
    Anal Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Lankenau Cancer Center at Lankenau Hospital
    Wynnewood, Pennsylvania 19096
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
    Lankenau Cancer Center at Lankenau Hospital
    Wynnewood, Pennsylvania 19096
    Breast Cancer
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Lankenau Cancer Center at Lankenau Hospital
    Wynnewood, Pennsylvania 19096
    Colorectal Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Lankenau Cancer Center at Lankenau Hospital
    Wynnewood, Pennsylvania 19096
    Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Lankenau Hospital

    Trial Locations
    Lankenau Hospital
    Mainline Health CCOP
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Endometrial Cancer, Fatigue, Neurotoxicity
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Lankenau Hospital
    Wynnewood, Pennsylvania 19096
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Ovarian Cancer, Sarcoma
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Lankenau Cancer Center at Lankenau Hospital

    Trial Locations
    Lankenau Cancer Center at Lankenau Hospital
    CCOP - Main Line Health
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Mainline Health CCOP
    Wynnewood, Pennsylvania 19096
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma